A critical discovery in cancer investigation is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor suppressor protein is frequently disabled in many types of malignancies, https://bookmarkpath.com/story21926066/vhh-fragments-restore-the-p53-protein-a-new-hope-for-cancer-management